Your browser doesn't support javascript.
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.
Lamb, Christopher A; Sebastian, Shaji; Kent, Alexandra J; Segal, Jonathan P; Gonzalez, Haidee A; Brookes, Matthew J; Mehta, Shameer J; Subramanian, Sreedhar; Bhala, Neeraj; Hicks, Lucy C; Conley, Thomas E; Patel, Kamal V; Walker, Gareth J; Kennedy, Nicholas A.
  • Lamb CA; Newcastle upon Tyne, UK.
  • Sebastian S; Hull, UK.
  • Kent AJ; London, UK.
  • Segal JP; London, UK.
  • Gonzalez HA; Hull, UK.
  • Brookes MJ; Wolverhampton, UK.
  • Mehta SJ; London, UK.
  • Subramanian S; Liverpool, UK.
  • Bhala N; Birmingham, UK.
  • Hicks LC; London, UK.
  • Conley TE; Liverpool, UK.
  • Patel KV; London, UK.
  • Walker GJ; Torquay, UK.
  • Kennedy NA; Exeter, UK.
Aliment Pharmacol Ther ; 53(11): 1236-1240, 2021 06.
Article in English | MEDLINE | ID: covidwho-1219506

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: Apt.16349

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: Apt.16349